文献速递冠心病外科

第三代机器人联合EndoWrist稳定器行全内镜冠状动脉旁路移植术1000例连续病例经验

Robotic totally endoscopic coronary bypass using a third-generation robot with the EndoWrist stabilizer: Insights from 1000 consecutive cases.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-09-07

该研究回顾性分析了单术者连续1035例机器人心脏不停跳全内镜冠状动脉旁路移植术(TECAB)的围术期结果,并按时间顺序分为4组各250例比较不同阶段的变化。全队列平均STS预测死亡风险1.43±2.1%,多支血管TECAB占54%,其中87%使用双侧乳内动脉桥,院内死亡率0.67%,早期桥血管通畅率97%。随时间推移,STS评分下降、多支血管TECAB比例下降、手术时间延长,但住院时间缩短、术后房颤减少,死亡和主要心脑血管不良事件保持低水平。

要点

  • 单术者1035例机器人不停跳TECAB,院内死亡率0.67%,早期桥血管通畅率97%。
  • 多支血管TECAB占54%,其中87%采用双侧乳内动脉桥,中转率仅0.09%。
  • 随机器人缝合替代吻合器,手术时间延长但住院时间缩短、术后房颤减少。

核心结论

  • 使用第三代机器人联合EndoWrist稳定器行机器人不停跳TECAB,在1035例连续病例中可取得持续优异的围术期结果。

研究设计与样本

  • 单中心单术者回顾性队列研究,纳入2013年7月至2026年3月连续1035例机器人不停跳TECAB患者,按时间顺序分为4组各250例比较围术期结局。

主要发现

  • 全队列平均STS预测死亡风险为1.43±2.1%,多支血管TECAB占54%,其中87%接受双侧乳内动脉桥。
  • 1676个吻合口中35%通过吻合装置完成、63%通过机器人缝合完成,术中中转1例(0.09%)。
  • 平均住院日2.26±0.9天,临床心肌梗死1例、卒中3例,院内死亡率0.67%(观察/预期0.47),早期桥血管通畅率97%。
  • 随时间推移STS评分下降(P = .006),多支血管TECAB比例从61%降至47%(P = .02),手术时间从251分钟增至294分钟(P = .002)。
  • 机器人缝合占比从98%降至0%(P < .001),住院时间从2.7天缩短至2.0天(P < .001),术后房颤从18%降至8%(P = .002)。

关键数值与推荐

  • 全队列平均STS预测死亡风险1.43±2.1%,院内死亡率0.67%,观察/预期比0.47,早期桥血管通畅率97%。
  • 杂交冠状动脉血运重建患者各阶段桥血管通畅率均>96%(P = .35)。
  • 早期死亡和主要心脑血管不良事件无时间差异(P = .384和P = .484)。

临床怎么用

  • 对于适合的患者,机器人不停跳TECAB可安全实现多支血管完全内镜下再血管化,尤其结合双侧乳内动脉桥。
  • 术者学习曲线中从吻合装置向机器人缝合过渡会延长手术时间,但可缩短住院时间并减少术后房颤。

局限性

  • 单中心、单术者回顾性研究,结果可能受术者经验和学习曲线影响,外推性有限。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In robotic-assisted coronary surgery, few programs use the robot to execute the complete procedure (totally endoscopic coronary artery bypass [TECAB]). We report lessons learned from >1000 consecutive TECAB cases at our institution. METHODS: In a retrospective review of 1035 patients undergoing robotic beating-heart TECAB (July 2013 to March 2026) by a single experienced surgeon, patients were divided chronologically into 4 groups of 250 cases each. Perioperative outcomes were compared across eras. RESULTS: In the whole cohort (n = 1035), the mean Society of Thoracic Surgeons Predicted Risk of Mortality was 1.43 ± 2.1%. Multivessel TECAB was performed in 54% of patients, of whom 87% received bilateral internal thoracic artery grafting. Of 1676 total anastomoses, 35% were via an anastomotic device; 63% via robotic suturing. There was 1 intraoperative conversion (0.09%). Mean length of stay was 2.26 ± 0.9 days. There was 1 clinical myocardial infarction and 3 strokes. Hospital mortality was 0.67% (observed/expected 0.47). Early graft patency was 97%. Across eras, Society of Thoracic Surgeons Predicted Risk of Mortality scores decreased (P = .006). Multivessel TECAB declined (61% to 47%, P = .02), whereas operative time increased (251 to 294 minutes, P = .002), coinciding with transition to robotic suturing from anastomotic devices (98% to 0%, P < .001) and increased trainee involvement. Conversion remained rare (1 early case). Hospital length of stay shortened (2.7 to 2.0 days, P < .001); postoperative atrial fibrillation decreased (18 to 8%, P = .002). Early mortality and major adverse cardiac and cerebrovascular events remained low with no temporal difference (P = .384 and P = .484, respectively). Among patients who underwent hybrid coronary revascularization, graft patency remained >96% across all eras (P = .35). CONCLUSIONS: In this series of 1035 patients who underwent robotic beating-heart TECAB via the third-generation robot with an EndoWrist stabilizer, we demonstrate that the procedure can be performed with consistent, excellent results. These findings support the sustainability of TECAB with the evolution of new robotic systems with EndoWrist stabilization.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Nisivaco S, Kitahara H, Al-Jamal Y, et al. Robotic totally endoscopic coronary bypass using a third-generation robot with the EndoWrist stabilizer: Insights from 1000 consecutive cases. J Thorac Cardiovasc Surg. 2026. PMID: 42705574. doi:10.1016/j.jtcvs.2026.08.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。